Praj Industries reported a steady Q2 FY27 performance with a ₹23 crore profit (up 20% YoY) and approved a ₹100 crore investment in a joint venture with BPCL to set up Compressed Bio-Gas (CBG) plants across India. Brokerages maintain a positive long-term outlook despite short-term ethanol project delays.
🧾 Key Financial Highlights (Q2 FY27)
Metric Q2 FY27 YoY Change
Revenue ₹849 crore +1%
EBITDA ₹52 crore +74% QoQ
PAT (Profit After Tax) ₹23 crore +20% YoY
Order Backlog ₹4,455 crore Stable
Bioenergy Share of Orders 75% —
Standalone Income: ₹6,741.52 million
Consolidated Income: ₹8,611.67 million
Consolidated PAT: ₹231.67 million
Audit Status: Reviewed by MSKA & Associates LLP
⚙️ Strategic Developments
BPCL Joint Venture:
Investment up to ₹100 crore approved on Oct 29, 2026.
Focus: Establishing 8–10 CBG plants nationwide (total project cost ₹800–1,000 crore).
Aligns with India’s green energy and sustainable fuel goals.
GenX Business Expansion:
Qualified with 18 global customers.
Active projects in oil & gas, fertilisers, and LNG sectors.
Bio-IBA Plant:
India’s first plant under construction, expected completion by end of 2026.
🌍 Market Outlook
Brokerage View:
Prabhudas Lilladher maintains a Buy rating with a target price of ₹353, citing strong international pipeline and diversification into data centres and biofuels.
Despite weak domestic ethanol execution, international projects worth ₹10 billion and data centre opportunities of ₹5–6 billion provide medium-term growth visibility.
Stock Performance:
Current price around ₹241.70, down 21% in the last month.
Valuation at 21× FY28E EPS, with long-term revenue target of ₹10,000 crore by FY30.
⚠️ Risks & Considerations
Domestic ethanol project delays due to funding constraints.
Execution risk in converting backlog to revenue.
Policy shifts in renewable energy could affect timelines.